Aktis Has First Biotech IPO of 2026, Elevating $318M to Develop the Attain of RadiopharmaceuticalsJanuary 9, 2026
US nabs one other ‘ghost fleet’ tanker in Caribbean raid, warns criminals: ‘There is no such thing as a protected haven’January 9, 2026
Share Facebook Twitter LinkedIn Pinterest WhatsApp Email AbbVie in talks to purchase biotech Revolution Medicines, WSJ stories
